
CRISPR-Edited TILs Fight Advanced Colorectal Cancer in Patients
Immunotherapeutic strategies have made huge strides in cancer treatment for many solid tumors over the past decade. But the promising results have failed to make a large change in the treatment of gastrointestinal forms of cancer. Now, a first-in-human …